Dixon Jonathan V. 4

What Happened Jonathan V. Dixon, General Counsel of Bionano Genomics (BNGO), had 6 shares of common stock withheld by the company on Feb 17, 2026 to satisfy tax withholding obligations related to RSUs that vested on Feb 15, 2026. The withholding was reported as a disposal at an effective price of $1.10 per share, totaling about $7. This is a routine tax-withholding transaction (code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-02-17; Form 4 filed: 2026-02-18 (Period of Report: 2026-02-17).
• Transaction type/code: F (tax withholding / shares surrendered to satisfy tax liability).
• Shares withheld/disposed: 6 shares at $1.10 each; total value ≈ $7.
• Footnote: Shares were withheld to satisfy tax obligations on RSUs that vested Feb 15, 2026 from an RSU award granted Feb 15, 2023.
• Shares owned after the transaction: not specified in the provided filing.
• Filing timeliness: Filed the day after the transaction (no late-filing flag indicated).

Context Tax withholding via share surrender (a cashless settlement mechanism) is common when RSUs vest and does not necessarily signal any change in the insider’s view of the stock. The amount here is immaterial (~$7) and routine. The F transaction code simply reflects the company withheld shares to cover withholding taxes upon RSU settlement.